SCHEMBL7329630

SCHEMBL7329630

OCCN1CCN(CCCc2ccccc2)CC1

nearest known ligand 0.81

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 12/20 0.81
CCR3 P51677 1/20 0.64
POLB P06746 1/20 0.64
LTA4H P09960 1/20 0.62
TSHR P16473 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11399131 0.93 SIGMAR1 (0.81) SIGMAR1CCR3POLBLTA4H
SCHEMBL2962629 0.90 SIGMAR1 (1.00) SIGMAR1CCR3POLBLTA4H
SCHEMBL6550825 0.90 SIGMAR1 (1.00) SIGMAR1CCR3POLBLTA4H
SCHEMBL10932016 0.85 SIGMAR1 (0.69) SIGMAR1CCR3
SCHEMBL3593088 0.83 SIGMAR1 (0.89) SIGMAR1CCR3POLBLTA4H
SCHEMBL11801794 0.83 CCR3 (0.89) SIGMAR1CCR3
SCHEMBL5302082 0.82 LTA4H (0.86) SIGMAR1CCR3POLBLTA4H
SCHEMBL8092982 0.82 SIGMAR1 (0.85) SIGMAR1CCR3TSHR
SCHEMBL14100161 0.82 SIGMAR1 (0.69) SIGMAR1LTA4H
SCHEMBL14824971 0.81 SIGMAR1 (0.81) SIGMAR1CCR3POLBLTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025058989-A1 NOVEL COMPOUNDS FOR TREATING CANCER MARSAL THERAPEUTICS, INC. (US) 2025-03-20 WO disclosed
US-5177077-A Inhibitors at dopamine uptake sites, treatment of mental disorders NOVO NORDISK A/S (DK) 1993-01-05 US disclosed
WO-1992001686-A1 1,4-DISUBSTITUTED PIPERAZINES NOVO NORDISK A/S (DK) 1992-02-06 WO disclosed
US-4265894-A TREATING PARKINSON'S DISEASE AND ACROMEGALY GIST BROCADES, N.V. (NL) 1981-05-05 US disclosed
US-4202896-A DOPAMINERGIC ACTIVITY GIST-BROCADES N.V. (NL) 1980-05-13 US disclosed